The risk-benefit balance in the United States: who decides?

Health Aff (Millwood). 2007 May-Jun;26(3):625-35. doi: 10.1377/hlthaff.26.3.625.

Abstract

A health policy decision often requires a balancing of risks, costs, and benefits. In this paper we illustrate that there is no uniform answer in the United States to the question of who decides the risk-benefit balance. We use a wide range of case examples from medicine and public health to show the different approaches that are used to allocate decision-making responsibility. Our ultimate purpose is to urge the U.S. health policy community to develop a more consistent way of thinking about how risk-benefit decisions could be guided by general principles.

Publication types

  • Comparative Study

MeSH terms

  • Air Bags / legislation & jurisprudence
  • Chromium / poisoning
  • Cyclooxygenase 2 Inhibitors / therapeutic use
  • Decision Making*
  • Drug Approval / legislation & jurisprudence
  • Health Policy*
  • Humans
  • Medicare / legislation & jurisprudence
  • Occupational Exposure / legislation & jurisprudence
  • Organizational Case Studies
  • Policy Making*
  • Risk Assessment / methods
  • Therapies, Investigational
  • United States

Substances

  • Cyclooxygenase 2 Inhibitors
  • Chromium
  • chromium hexavalent ion